Synthesis and evaluation of 5' alkyl ester prodrugs of zidovudine for directed lymphatic delivery

International Journal of Pharmaceutics

Volumn 144, Issue 1, 1996, Pages 61-70

  Bibby, David C ^a   Charman, William N ^a   Charman, Susan A ^a   Iskander, Magdy N ^a   Porter, Christopher J H ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Alkyl ester prodrugs; AZT; Lymph; Lymphatic transport; Zidovudine

Indexed keywords

PRODRUG; ZIDOVUDINE; ZIDOVUDINE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG SYNTHESIS; DRUG TRANSPORT; INTESTINE LYMPH; INTRAGASTRIC DRUG ADMINISTRATION; LYMPHATIC SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030598290     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(96)04720-5     Document Type: Article

References (21)

1. Charman, W.N. and Porter, C.J.H., Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug, Del. Rev., 19 (1996) 149-169.
2. Charman, W.N.A. and Stella V.J., Estimating the maximum potential for intestinal lymphatic transport of lipophilic drug molecules. Int. J. Pharm., 34 (1986) 175-178.
3. Charman, W.N. and Stella, V.J., (Eds), Lymphatic Transport of Drugs, CRC Press, Boca Raton, FL, 1992.
4. Czernecki, S. and Valéry, J.-M., An efficient synthesis of 3′-azido-3′-deoxythymidine (AZT). Synthesis, 3 (1991) 239-240.
5. Fischl, M.A., Richman, D.D., Grieco, M.H., Gottlieb, M.S., Volberding, P.A., Laskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Schooley R.T., Jackson, G.G., Durack, D.T and King, D., The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled study. N. Engl. J. Med., 317 (1987) 185-191.
6. Hernell, O., Staggers, J.E. and Carey, M.C., Physical-chemical behaviour of dietary and biliary lipids during intestinal digestion and absorption. 2. Phase analysis and aggregation states of luminal lipids during duodenal fat digestion in healthy adult human beings. Biochemistry, 29 (1990) 2041-2056.
7. Hostetler, K.Y., Stuhmiller, L.M., Lenting, H.B.M., van den Bosch, H. and Richman, D.D., Synthesis and antiretroviral activity of phospholipid analogs of azidothymidine and other antiviral nucleosides, J. Biol. Chem., 265 (1990) 6112-6117.
8. Hosteller, K.Y., Richman, D.D., Forssen, E.A., Selk, L., Basava, R., Gardner, M.F., Parker, S. and Basava, R., Phospholipid prodrug inhibitors of the HIV protease. Biochem. Pharmacol., 48 (1994) 1399-1404.
9. Kawaguchi, T., Ishikawa, K., Seki, T. and Juni, K., Ester prodrugs of zidovudine. J. Pharm. Sci., 79 (1990) 531-533.
10. Kawaguchi, T., Endoh, T., Seki, T. and Juni, K., Plasma concentrations of zidovudine in rats via oral administration of its ester prodrugs. J. Pharm. Sci., 80 (1991) 404-405.
11. Mack, F. and Bönisch, H., Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn-Schmiedeberg's Arch. Pharmacol., 310 (1979) 1-9.
12. Noguchi, T., Charman, W.N.A. and Stella, V.J., Lymphatic appearance of DDT in thoracic or mesenteric lymph duct cannulated rats. Int. J. Pharm., 24 (1985) 185-192.
13. Pantaleo, G., Graziosi, C., Butini, L., Pizzo, P.A., Schnittman, S.M., Kotler, D.P. and Fauci, A.S., Lymphoid organs function as major reservoirs for human immunodeficiency virus. Proc. Natl. Acad. Sci. USA, 88 (1991) 9838-9842.
14. Pantaleo, G., Graziosi, C., Demarest, J.F., Butini, L., Montroni, M., Fox, C.H., Orenstein, J.M., Kotler, D.P. and Fauci, A.S., HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature, 362 (1993) 355-358.
15. Porter, C.J.H. and Charman W.N., Uptake of drugs into the intestinal lymphatics after oral administration. Adv. Drug Del. Rev., (1996a) in press.
16. Porter, C.J.H. and Charman, W.N., Model systems for intestinal lymphatic transport studies. In Wilson, G., Borchardt, R.T. and Smith, P.L. (Eds), Model Systems for Biopharmaceutical Assessment of Drug Absorption and Metabolism, Plenum, New York, 1996b, pp. 85-102.
17. Porter, C.J.H., Charman, S.A. and Charman, W.N., Lymphatic transport of halofantrine in the triple cannulated anesthetized rat model: effect of lipid vehicle dispersion. J. Pharm. Sci., 85 (1996) 351-356.
18. Sakai, A., Mori, N., Shuto, S. and Suzuki, T., Deacylation-reacylation cycle: a possible absorption mechanism for the novel lymphotropic antitumor agent dipalmitoyl-phosphatidylfluorouridine in rats. J. Pharm. Sci., 82 (1993) 575-578.
19. Sugihara, J., Furuuchi, S., Nakano, K. and Harigaya, S., Studies on the intestinal lymphatic absorption of drugs. I. Lymphatic absorption of alkyl ester derivatives and α-monoglyceride derivatives of drugs. J. Pharmacobio-Dyn., 11 (1988a) 369-376.
20. Sugihara, J., Furuuchi, S., Ando, H., Takashima, K. and Harigaya, S., Studies on the intestinal lymphatic absorption of drugs. II. Glyceride prodrugs for improving the lymphatic absorption of naproxen and nicotinic acid. J. Pharmacobio-Dyn., 11 (1988b) 555-562.
21. Westerman, J. and Pabst, R., Lymphocyte subsets in the blood: a diagnostic window on the lymphoid system? Immunol. Today, 11 (1990) 406-410.